These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 19112225)
1. HLA class I and II antigens expression in patients with renal cell carcinoma. Ozgur BC; Gonenc F; Yazicioglu AH Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225 [TBL] [Abstract][Full Text] [Related]
2. Characterization of HLA-G expression in renal cell carcinoma. Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data. Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593 [TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma. Ozdemir E; Kakehi Y; Nakamura E; Kinoshita H; Terachi T; Okada Y; Yoshida O Cancer Res; 1997 Feb; 57(4):742-6. PubMed ID: 9044854 [TBL] [Abstract][Full Text] [Related]
5. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559 [TBL] [Abstract][Full Text] [Related]
8. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Abanmi A; Al Harthi F; Al Baqami R; Al Assaf S; Zouman A; Arfin M; Tariq M Arch Dermatol Res; 2006 Dec; 298(7):347-52. PubMed ID: 17021767 [TBL] [Abstract][Full Text] [Related]
9. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation. Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977 [TBL] [Abstract][Full Text] [Related]
10. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue. Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575 [TBL] [Abstract][Full Text] [Related]
11. Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls. Goebel S; Kehlen A; Bluemke K; Altermann W; Schlaf G; Fischer K; Fornara P; Wullich B; Wach S; Taubert H Cancer Immunol Immunother; 2017 May; 66(5):565-571. PubMed ID: 28184970 [TBL] [Abstract][Full Text] [Related]
12. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy. Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235 [TBL] [Abstract][Full Text] [Related]
13. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Luboldt HJ; Kubens BS; Rübben H; Grosse-Wilde H Cancer Res; 1996 Feb; 56(4):826-30. PubMed ID: 8631020 [TBL] [Abstract][Full Text] [Related]
14. Structure, expression and function of HLA-G in renal cell carcinoma. Seliger B; Schlaf G Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652 [TBL] [Abstract][Full Text] [Related]
15. HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma. Komohara Y; Harada M; Ishihara Y; Suekane S; Noguchi M; Yamada A; Matsuoka K; Itoh K Oncol Rep; 2007 Dec; 18(6):1463-8. PubMed ID: 17982631 [TBL] [Abstract][Full Text] [Related]
16. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer. Bulut I; Meral M; Kaynar H; Pirim I; Bilici M; Gorguner M Lung Cancer; 2009 Nov; 66(2):231-6. PubMed ID: 19246116 [TBL] [Abstract][Full Text] [Related]
17. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052 [TBL] [Abstract][Full Text] [Related]
19. HLA class I and class II genotyping in patients with chronic urticaria. Coban M; Erdem T; Ozdemir S; Pirim I; Atasoy M; Ikbal M Int Arch Allergy Immunol; 2008; 147(2):135-9. PubMed ID: 18520158 [TBL] [Abstract][Full Text] [Related]
20. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Pirim I; Atasoy M; Ikbal M; Erdem T; Aliagaoglu C Tissue Antigens; 2004 Sep; 64(3):293-7. PubMed ID: 15304011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]